drugset / Trial / NCT02726035

Evaluation of Naltrexone as a Treatment for Self-injurious Behavior

NCT02726035

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The proposed study examines the effect of oral naltrexone on self-injurious behavior (SIB) in adolescents and adults of normal intelligence.

Timeline

Start
2014-02-22
Primary completion
2015-06-30
Completion
2017-01-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule 50 mg Oral